Navigation Links
XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution
Date:8/5/2009

MENLO PARK, Calif., Aug. 5 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced that it has provided written notice to The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. The Company currently anticipates that, on or about August 17, 2009, the Company will file with the Securities and Exchange Commission and NASDAQ a Form 25 relating to the delisting of XTENT's common stock. XTENT expects that trading in its common stock will be permanently suspended by NASDAQ effective at the open of trading on August 17, 2009, with official delisting of the common stock effective 10 days thereafter, on or about August 27, 2009, at which time XTENT's transfer agent will close the stock transfer records and discontinue recording transfers of the common stock.

XTENT also announced today the filing of its Certificate of Dissolution with the Secretary of State of the State of Delaware, with an effective date of August 27, 2009.

The voluntary delisting of XTENT's common stock from NASDAQ and the filing of the Certificate of Dissolution are being undertaken pursuant to the Plan of Complete Liquidation and Dissolution approved by XTENT's stockholders on August 3, 2009.

For further information, please visit our website at http://www.xtentinc.com/.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve ris
'/>"/>

SOURCE XTENT, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. XTENT, Inc. Announces That It Has Postponed the Special Meeting of Its Stockholders
2. Snoring Isn't Sexy, LLC Launches Survey to Determine Extent of Drowsy Drivers on Land, Sea and In The Air
3. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
4. To what extent can environmental pollutants and alcohol affect GI health?
5. XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials With the SEC
6. XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
7. XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress
8. APIC Covers Up Extent and Causes of Deadly C. diff
9. XTENT Announces Third Quarter 2008 Financial Results
10. XTENT Announces Second Quarter 2008 Financial Results and Business Progress
11. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...dy accepted for publication in The Endocrine Socie...sm ( JCEM ), youth with type 1 diabetes have now ...aving abnormal insulin resistance appears to negat...tion in this population. , Type 1 diabetes ofte...es have their insulin resistance measured routinel...
(Date:12/1/2009)...- Sentinelle Medical Inc., a leading manufacturer ...software, extends its line of award winning breast...h America (RSNA) annual meeting in Chicago, Nov. 3...the unique Vanguard(R) patient support design and ...,s line of breast coils are recognized for deliver...
(Date:12/1/2009)...z, a fourth-year medical student at Ross Universit...nal medicine to help fulfill an unmet need. , ...ecember 1, 2009 -- Having distinguished himself wi...tions, Craig Moskowitz--a fourth-year medical stud... could go into any area of medicine that he chose....
(Date:12/1/2009)...dan Fiddle Foundation, a national autism organizat... support programs and services for adolescents and...released a free informational brochure entitled &q...nize The Signs and Basic First Aid When You Do.&qu...) December 1, 2009 -- Statistics show that as many...
(Date:12/1/2009)...wswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)...at the 21st Annual Piper Jaffray Health Care Confe... Time will be webcast live at www.celltherapeutic...n Holmes 1 at the New York Palace Hotel, and will ...n. , , Piper Jaffray Health ...
Breaking Medicine News(10 mins):Health News:Cardiovascular risk in youth with type 1 diabetes linked primarily to insulin resistance 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 3Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4
...ry issue of Archives of General Psychiatry, one of...specially physical signs, such as// fatigue and lo...rteries, which may reflect an early sign of corona...ery disease, which occurs when the vessels carryin...
...ine journal PLoS Biology concluded that the low le... in the central nervous system to// prematurely sh... identify a common molecular trigger for the effec...s. While scientists have long understood that...
...a from 55 developing countries has shown that, a ‘...e rest of society.// It was already well know...risen over several decades, but it was not clear w...ealth Organization HQ in Geneva brought together d...
...ment to gender equality, women are still underrepr...hile the impact of gender differences// continues ... in the Journal of Medical Ethics. The autho...ria and The Netherlands in 2003. Before rese...
...Australia is an ongoing problem according to Austr...// In the latest edition of the Medical Jou...r address some of the issues surrounding organ don...or rates, and the third the participation of priso...
...uccumb to bird flu, bringing the death toll from t...ssan el-Bushra, regional adviser for communicable ...ation said the girl was believed to have been infe... Bushra said she had started showing symptoms of t...
Other Medicine News:Health News:Symptoms of Depression Associated With Artery Diseases 2Health News:Environmental Toxicants Target Stem Cells 2Health News:Environmental Toxicants Target Stem Cells 3Health News:European Medical Research Still Ignoring Women 2Health News:The Search for Organ Donors 2
(Date:11/30/2009)...Newswire/ -- Microban International, Ltd., the glo...ction, is pleased to announce their exclusive Nort...gest U.S. manufacturer and distributor of ceramic ...g two new lines of ceramic tile with OutStand Tech...ng silver based technology, in order to create a l...
(Date:11/30/2009)...RNewswire-FirstCall/ -- Nektar Therapeutics (Nasda...ne Masuoka, M.D. to Senior Vice President and Chie...ly to Nektar,s President and Chief Executive Offic...ng leadership and highly effective clinical develo... advancing Nektar,s proprietary clinical pipeline,...
(Date:11/30/2009)... Breast-Specific Gamma Imaging (BSGI) significantl...h-risk lesions in patients with negative or indete...s of a multicenter study presented today at the an...America (RSNA). ,, In this retrospective study,...ng modality at four institutions and was compared ...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2Quality of Medicines Advanced by Agreement Between USP Mexican Standards Body 55335 1Quality of Medicines Advanced by Agreement Between USP Mexican Standards Body 55335 2ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once Daily Xibrom 28TM 29 0 09 25 4897 1ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once Daily Xibrom 28TM 29 0 09 25 4897 2ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once Daily Xibrom 28TM 29 0 09 25 4897 3More Women Surviving After Early Breast Cancer 55327 1More Women Surviving After Early Breast Cancer 55327 2More Women Surviving After Early Breast Cancer 55327 3
...mory Imprint to Yield a Strong and ...g. 20 Intellect Neurosciences,Inc. (OTC Bulletin ...n,development of disease-modifying therapeutic age...s disease and related disorders, announced today,t... present new data,regarding the Company,s RECALL-V...
...r Coiling Since Groundbreaking 2002 ... 1 A new study reveals that,coiling, a minimally ..., is,successful in preventing recurrent or first-t...e aneurysms considered "untouchable" by the,tradit... findings since the,2002 release of the Internatio...
Other Medicine Technology:Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference 2Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference 3New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 2New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results 3
Optima III Noninsulated Babcock Grasper, with ratchet
Optima III Noninsulated Retraction Grasper, with ratchet
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Medicine Products: